Results 211 to 220 of about 1,118,702 (266)
Effect of rhPTH(1-34) and alendronate on the treatment of type 2 diabetic bone disease. [PDF]
Front Endocrinol (Lausanne)Li H +9 more
europepmc +1 more source
Reclassification of Hypophosphatemic Bone Disease as X-Linked Hypophosphatemia Following Genetic Testing in Adulthood. [PDF]
AACE Endocrinol DiabetesKamel L +4 more
europepmc +1 more source
Role of sclerostin in mastocytosis bone disease. [PDF]
Sci RepSzudy-Szczyrek A +18 more
europepmc +1 more source
Treatment of myeloma bone disease: When, how often, and for how long? [PDF]
J Bone OncolGundesen MT, Schjesvold F, Lund T.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
New England Journal of Medicine, 2013
Paget’s disease of bone (PDB) affects up to 1% of people of European origin aged 55 years and above. It is characterized by focal abnormalities of bone remodelling which disrupt normal bone architecture, leading to expansion and reduced mechanical strength of affected bones.
Stuart H Ralston, Ralston Stuart H
exaly +2 more sources
Paget’s disease of bone (PDB) affects up to 1% of people of European origin aged 55 years and above. It is characterized by focal abnormalities of bone remodelling which disrupt normal bone architecture, leading to expansion and reduced mechanical strength of affected bones.
Stuart H Ralston, Ralston Stuart H
exaly +2 more sources
Endocrinology and Metabolism Clinics of North America, 2015
Pituitary hormones have direct and indirect effects on bone remodeling, and skeletal fragility is a frequent complication of pituitary diseases. Fragility fractures may occur in many patients with prolactinomas, acromegaly, Cushing disease, and hypopituitarism.
MAZZIOTTI, Gherardo +2 more
openaire +4 more sources
Pituitary hormones have direct and indirect effects on bone remodeling, and skeletal fragility is a frequent complication of pituitary diseases. Fragility fractures may occur in many patients with prolactinomas, acromegaly, Cushing disease, and hypopituitarism.
MAZZIOTTI, Gherardo +2 more
openaire +4 more sources
Calcified Tissue International, 2019
Paget's disease of bone (PDB) is a chronic and focal bone disorder, characterized by increased osteoclast-mediated bone resorption and a subsequent compensatory increase in bone formation, resulting in a disorganized mosaic of woven and lamellar bone at one or more affected skeletal sites.
Luigi Gennari +3 more
openaire +5 more sources
Paget's disease of bone (PDB) is a chronic and focal bone disorder, characterized by increased osteoclast-mediated bone resorption and a subsequent compensatory increase in bone formation, resulting in a disorganized mosaic of woven and lamellar bone at one or more affected skeletal sites.
Luigi Gennari +3 more
openaire +5 more sources